Morning Immunotherapy Effect in Question as Key Study Is Retracted
TL;DR
Nature Medicine retracted a Chinese trial that claimed morning administration of immunotherapy yielded dramatic cancer benefits, citing concerns about data integrity; the ruling undermines the reported timing advantage and leaves clinicians cautious about changing practice.
- Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning The New York Times
- Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints News
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing Fierce Pharma
- Discussions Around Retraction of Debated Study on Early Morning Immunotherapy Benefits Oncodaily
- Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation Applied Clinical Trials Online
Want the full story? Read the original reporting
Read on The New York Times